drugset
drugset / Trial / NCT04712500

A Food-Effect Study of AND017 in Healthy Participants

NCT04712500 ↗

Phase 1 Completed 14 enrolled Kind Pharmaceuticals LLC
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this phase I study is to evaluate the food effect on the PKs of AND017 following oral single-dose administration in healthy non-elderly Chinese subjects.

Timeline

Start
2020-07-30
Primary completion
2020-08-16
Completion
2020-08-21

Drugs

EvaluationDrugModalityDoseRoute
Subject AND017 Unknown — Oral

Indications

No indication recorded.